China’s new NASDAQ-style market saw a week of wild swings as frenzied investors sent the start-up shares to “ridiculously” high levels, analysts said, warning that a correction is on the cards.
The 28 stocks on the ChiNext board in the southern boomtown of Shenzhen repeatedly tripped circuit-breakers in place to curb rampant speculation as keen buyers ignored warnings from regulators to trade in a “rational” way.
After a massive debut surge for all shares on Oct. 30, with some soaring as much as 210 percent amid feverish buying, subsequent sessions saw stocks see-sawing up and down by the 10 percent limit in place on all Chinese bourses.
PHOTO: AFP
“I think it was crazy — the rise was ridiculously high,” said Peter Lai (黎永良), a director of DBS Vickers in Hong Kong. “Chinese investors are not very rational.”
Yan Li, a Beijing-based analyst at Southwest Securities, said the casino-style trading “shows that investors lack an understanding of the risks.”
“Traditionally Chinese investors tend to chase after new stocks and such a trend will continue. I think the ChiNext board is very likely to see big fluctuations in the future,” Yan said.
Ahead of the start of ChiNext trade, the chairman of the China Securities Regulatory Commission, Shang Fulin (尚福林), cautioned investors by saying start-up stocks have potential for strong growth — but also unstable financial results.
The board is expected to give small and medium-sized companies access to financing and to encourage private equity firms and venture capitalists to back start-ups, in the tradition of New York’s NASDAQ.
The first 28 companies to list on the board, ranging from movie producers to medical equipment makers, raised about 16 billion yuan (US$2.3 billion) in their initial public offerings — more than double initial forecasts.
Observers had been worried that ChiNext would draw funds away from the main boards and depress share prices. But so far, the second board appears to have had little impact on main board trading.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained